Centers for Research on Neglected Infectious Diseases
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Oct 9, 2026
Can you apply?
This grant is for research institutions and universities conducting multidisciplinary research on neglected infectious diseases. Eligible applicants must have capacity to conduct epidemiological, pathogenesis, diagnostic, treatment, and prevention research on parasitic and other communicable infectious diseases. The focus includes building sustainable research capacity in endemic regions while strengthening US global research networks. Projects should address early identification, containment, and mitigation of infectious diseases at their sources.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Oct 6, 2026 Applications open
- Jun 15, 2027 Application deadline in 248 days
- Mar 1, 2028 Award announced
- Mar 1, 2028 Project start
Program description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting multidisciplinary research through the Centers for Research on Neglected Infectious Diseases (CReNIDs). Neglected infectious diseases (NIDs) comprise a diverse and understudied group of communicable viral, bacterial, parasitic, and fungal infections that cause substantial morbidity, mortality, and long-term health consequences worldwide. This new research program will emphasize the epidemiology, pathogenesis, diagnosis, treatment, and prevention of communicable parasitic NIDs in endemic regions and build sustainable in-country research capacity and expertise. The overarching goal is to protect and improve the health of the American people by strengthening US and global multidisciplinary research and training on NIDs to enable early identification, containment, and mitigation of infectious diseases at their sources, thereby reducing the risk of their spread to and within the United States. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (R&R) or SF-424 (R&R) application
- Project Narrative (research plan)
- Budget and Budget Narrative
- Biographical sketches of key personnel
- Letters of support from international partners
- Institutional commitments documentation
- Previous NIH grant performance reports (if applicable)
Program contact
- 👤 CreNID (Division of Microbiology and Infectious Diseases)
- 📧 CreNID@mail.nih.gov
- 📞 Please contact via email.
Funding track record
Recent awards under CFDA 93.855 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$246,626,852
-
$201,437,825
-
$197,316,803
-
$180,737,624
-
$147,765,880
-
$116,817,868
-
$93,394,862
-
$89,845,851
-
$85,436,674
-
$84,525,882
Top States by Funding
- CA 8 awards $744.5M
- MA 6 awards $616.6M
- NY 7 awards $377.2M
- TX 3 awards $292.4M
- GA 5 awards $265.7M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.855). How funding has trended year over year.
| 2024 | $4,073,812,529 | |
| 2025 | $4,378,235,639 | |
| 2026 est. | $4,299,426,996 |
FAQ
Who can apply for this grant?
Research institutions, universities, and organizations with strong research capacity in infectious disease are eligible. International partners in endemic regions can participate as collaborators.
What is the application deadline?
The deadline is June 15, 2027. This is a fixed deadline, not rolling.
What research activities are supported?
Epidemiology, pathogenesis, diagnosis, treatment, and prevention research on neglected infectious diseases. Capacity building in endemic countries is prioritized.
How competitive is this grant?
This is a highly competitive NIH program. Strong preliminary data, experienced teams, and focus on parasitic diseases strengthen applications.
What is the funding range?
The total program funding is $4.2 million. Individual award amounts vary based on project scope and institutional capacity.
💡 Tips for applicants
- Focus on parasitic neglected infectious diseases in endemic regions with clear US global health impact.
- Emphasize multidisciplinary collaboration and sustainable in-country research capacity building.
- Include letters of support from partner organizations in endemic regions demonstrating commitment to collaboration.
- Demonstrate how your research will enable early identification and containment at disease sources.
- Address both scientific innovation and training components to strengthen the research workforce.
⚠️ Common mistakes
Failing to address parasitic diseases specifically or neglecting capacity-building components in endemic regions. Insufficient demonstration of US global health security benefits or weak international partnerships. Proposing research without clear epidemiological relevance to communicable disease containment.
Similar grants
- OPEN NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) — National Institutes of Health
- OPEN Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases — National Institutes of Health
- OPEN Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) — National Institutes of Health
- CLOSED Global Infectious Diseases Research Training Program (D43 Clinical Trial Optional) — National Institutes of Health